Direct Medical Costs of Complications Resulting From Type 2 Diabetes in Hie U.S.
The DOI matches its Crossref record.
Abstract
OBJECTIVE: To estimate direct medical costs of managing the complications of type 2 diabetes. RESEARCH DESIGN AND METHODS: Costs were estimated for 15 diabetic complications by applying unit costs to typical resource-use profiles. Resource use and unit costs were estimated from many sources, including acute care discharge databases, clinical guidelines, government reports, fee schedules, and peer-reviewed literature. For each complication, the event costs are those associated with resource use that is specific to the acute episode and any subsequent care occurring in the 1st year. State costs are the annual costs of continued management. All costs are expressed in 1996 U.S. dollars. RESULTS: As expected, the more severe or debilitating events, such as acute myocardial infarction ($27,630 event cost; $2,185 state cost), generate a greater financial burden than do early-stage complications, such as microalbuminuria ($62 event cost; $14 state cost). Yet, complications that are initially relatively low in cost (e.g., microalbuminuria) can progress to more costly advanced stages (e.g., end-stage renal disease, $53,659 state cost); therefore, minor complications should also be considered in any economic analysis of diabetes. CONCLUSIONS: The recent literature has lacked cost estimates that may be readily translated into patient-level cost inputs for an economic model. Emerging therapies that may reduce the incidence of some diabetic complications will need to be scrutinized economically in today's cost-conscious environment. The cost estimates from this study provide one piece of the economic analysis needed to evaluate these new interventional therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Eyre, H., Kahn, R., Robertson, R. M., the ACS/ADA/AHA Collaborative Writing Committee, ACS/ADA/AHA Collaborative Writing Committee Members, Clark, N. G., Doyle, C., Hong, Y., Gansler, T., Glynn, T., et al. (2004) · Circulation · doi:10.1161/01.cir.0000133321.00456.00 · Cited by 542
The CDC Diabetes Cost-effectiveness Group (2002) · JAMA · doi:10.1001/jama.287.19.2542 · Cited by 508
Assessing the impact of complications on the costs of Type II diabetes
Williams, R., Van Gaal, L., & Lucioni, C. (2002) · Diabetologia · doi:10.1007/s00125-002-0859-9 · Cited by 353
Eyre, H., Kahn, R., Robertson, R. M., and the ACS/ADA/AHA Collaborative Writing Committee, Clark, N. G., Doyle, C., Gansler, T., Glynn, T., Hong, Y., Smith, R. A., et al. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.4.190 · Cited by 329
Comorbidity in patients with diabetes mellitus: impact on medical health care utilization
Struijs, J. N., Baan, C. A., Schellevis, F. G., Westert, G. P., & van den Bos, G. A. (2006) · BMC Health Services Research · doi:10.1186/1472-6963-6-84 · Cited by 277
Metadata
- Authors
- O'Brien, J. A., Shomphe, L. A., Kavanagh, P. L., Raggio, G., & Caro, J. J.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1998-07-01
- Volume
- 21
- Issue
- 7
- Pages
- 1122-1128
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2067707372
- Cited by
- 151
- References
- 0
- FWCI
- 21.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Direct Medical Costs of Complications Resulting From Type 2 Diabetes in Hie U.S. https://app.cochat.ai/papers/10.2337/diacare.21.7.1122
- The paper
- O'Brien, J. A., Shomphe, L. A., Kavanagh, P. L., Raggio, G., & Caro, J. J. (1998). Direct Medical Costs of Complications Resulting From Type 2 Diabetes in Hie U.S. Diabetes Care. https://doi.org/10.2337/diacare.21.7.1122
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.